Advertisement

Intensive Care Medicine

, Volume 45, Issue 2, pp 243–245 | Cite as

Infectious diseases: the 10 common truths I never believed

  • Jordi RelloEmail author
  • Emine Alp
  • Kalwaje Eshwara Vandana
What's New in Intensive Care
The field of infectious diseases has caught us with many surprises. Even in the time of modern medicine, evolutionary perspectives on disease biology and management have continued to challenge us from time to time (Fig.  1). Integration of knowledge from various fields of science has opened an exciting arena, ruffling our beliefs learned in medical schools or during practice of clinical medicine. Ten selected topics that developed under the influence of certain evolutionary factors in medicine are presented in Table  1.

Notes

Acknowledgements

Authors acknowledge the participation of experts who helped in the choice of the selected topics: Marcio Sa Borges, Rafael Zaragoza, Ricard Jorda and Yolanda Peña-Lopez.

Compliance with ethical standards

Conflicts of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Jain S, Self WH, Wunderink RG et al (2015) Community-acquired pneumonia requiring hospitalization among US adults. N Engl J Med 373:415–427.  https://doi.org/10.1056/NEJMoa1500245 CrossRefGoogle Scholar
  2. 2.
    Delport JA, Strikwerda A, Armstrong A et al (2017) MALDI-ToF short incubation identification from blood cultures is associated with reduced length of hospitalization and a decrease in bacteremia associated mortality. Eur J Clin Microbiol Infect Dis 36:1181–1186.  https://doi.org/10.1007/s10096-017-2906-y CrossRefGoogle Scholar
  3. 3.
    Daikos GL, Markogiannakis A (2011) Carbapenemase-producing Klebsiella pneumoniae: (When) might we still consider treating with carbapenems? Clin Microbiol Infect 17:1135–1141CrossRefGoogle Scholar
  4. 4.
    De Pascale G, Martucci G, Montini L et al (2017) Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case-control study. Crit Care.  https://doi.org/10.1186/s13054-017-1769-z Google Scholar
  5. 5.
    Rello J, van Engelen TSR, Alp E et al (2018) Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases. Clin Microbiol Infect.  https://doi.org/10.1016/j.cmi.2018.03.011 Google Scholar
  6. 6.
    Klompas M, Speck K, Howell MD et al (2014) Reappraisal of routine oral care with chlorhexidine gluconate for patients receiving mechanical ventilation: systematic review and meta-analysis. JAMA Intern Med 174:751–761.  https://doi.org/10.1001/jamainternmed.2014.359 CrossRefGoogle Scholar
  7. 7.
    Deschepper M, Waegeman W, Eeckloo K et al (2018) Effects of chlorhexidine gluconate oral care on hospital mortality: a hospital-wide, observational cohort study. Intensive Care Med.  https://doi.org/10.1007/s00134-018-5171-3 Google Scholar
  8. 8.
    Solé-Lleonart C, Rouby JJ, Blot S et al (2017) Nebulization of antiinfective agents in invasively mechanically ventilated adults: a systematic review and meta-analysis. Anesthesiology 126:890–908.  https://doi.org/10.1097/ALN.0000000000001570 CrossRefGoogle Scholar
  9. 9.
    Rello J, Solé-Lleonart C, Rouby JJ et al (2017) Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases. Clin Microbiol Infect 23:629–639.  https://doi.org/10.1016/j.cmi.2017.04.011 CrossRefGoogle Scholar
  10. 10.
    Alp E, Eren E, Elay G et al (2017) Efficacy of loading dose of colistin in Acinetobacter baumannii ventilator-associated pneumonia. Infez Med 25:311–319Google Scholar
  11. 11.
    Pogue JM, Ortwine JK, Kaye KS (2015) Editorial commentary: optimal usage of colistin: are we any closer? Clin Infect Dis 61:1778–1780.  https://doi.org/10.1093/cid/civ723 CrossRefGoogle Scholar
  12. 12.
    Borgatta B, Gattarello S, Mazo CA et al (2017) The clinical significance of pneumonia in patients with respiratory specimens harbouring multidrug-resistant Pseudomonas aeruginosa: a 5-year retrospective study following 5667 patients in four general ICUs. Eur J Clin Microbiol Infect Dis 36:2155–2163.  https://doi.org/10.1007/s10096-017-3039-z CrossRefGoogle Scholar
  13. 13.
    Roberts JA, Paul SK, Akova M et al (2014) DALI: defining antibiotic levels in intensive care unit patients: are current ß-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis 58:1072–1083.  https://doi.org/10.1093/cid/ciu027 CrossRefGoogle Scholar
  14. 14.
    Garcia-Vidal C, Barba P, Arnan M et al (2011) Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients. Clin Infect Dis 53:e16–e19.  https://doi.org/10.1093/cid/cir485 CrossRefGoogle Scholar
  15. 15.
    Uyeki TM, Mehta AK, Davey RT et al (2016) Clinical management of ebola virus disease in the United States and Europe. N Engl J Med 374:636–646.  https://doi.org/10.1056/NEJMoa1504874 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature and ESICM 2018

Authors and Affiliations

  1. 1.Vall d’Hebron Barcelona Campus HospitalBarcelonaSpain
  2. 2.CIBERES, Instituto Salud Carlos IIIMadridSpain
  3. 3.Erciyes UniversityKayseriTurkey
  4. 4.Kasturba Medical CollegeManipal Academy of Higher EducationManipalIndia

Personalised recommendations